Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
E O'Sullivan, Anna Keogh, Brian E. Henderson, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1635-1635
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Cutting-Edge Therapies for Lung Cancer
Anita Silas La’ah, Shih‐Hwa Chiou
Cells (2024) Vol. 13, Iss. 5, pp. 436-436
Open Access | Times Cited: 9
Dendritic Cells in Shaping Anti-Tumor T Cell Response
Luciano Mazzoccoli, Bei Liu
Cancers (2024) Vol. 16, Iss. 12, pp. 2211-2211
Open Access | Times Cited: 9
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance
Leonard J. Ash, Ottavia Busia-Bourdain, Daniel Okpattah, et al.
Current Oncology (2024) Vol. 31, Iss. 4, pp. 2024-2046
Open Access | Times Cited: 8
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
Lova Sun, Elizabeth A. Handorf, Yunyun Zhou, et al.
Lung Cancer (2024) Vol. 190, pp. 107510-107510
Closed Access | Times Cited: 6
Cutting-Edge Therapies for Lung Cancer
Anita Silas La’ah, Shih-Hwa Chiou
(2024)
Open Access | Times Cited: 5
The significance of chirality in contemporary drug discovery-a mini review
Narmatha Senkuttuvan, Boopathi Komarasamy, Rajavenkatesh Krishnamoorthy, et al.
RSC Advances (2024) Vol. 14, Iss. 45, pp. 33429-33448
Open Access | Times Cited: 5
Exploring Cellular Plasticity and Resistance Mechanisms in Lung Cancer: Innovations and Emerging Therapies
Caiyu Jiang, Shenglong Xie, Kegang Jia, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101179-101179
Open Access
Reducing pERKs to Break “RAS”istance to Sotorasib
Steven G. Gray, Derbrenn O'Connor, Luciano Mutti, et al.
Journal of Thoracic Oncology (2025) Vol. 20, Iss. 3, pp. 259-261
Closed Access
Second-line therapy for KRAS-positive metastatic non-small cell lung cancer
Martin Svatoň
Onkologie (2025) Vol. 19, Iss. 1, pp. 29-32
Closed Access
Small molecule anticancer drugs approved during 2021–2022: Synthesis and clinical applications
T. N. Rekha, Arifullah Mohammed
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116441-116441
Closed Access | Times Cited: 3
Smoking and pulmonary health in women: A narrative review and behavioral health perspective
Katherine E. Menson, Sulamunn R.M. Coleman
Preventive Medicine (2024) Vol. 185, pp. 108029-108029
Closed Access | Times Cited: 3
Targeted and cytotoxic inhibitors used in the treatment of lung cancers
Robert Roskoski
Pharmacological Research (2024), pp. 107465-107465
Open Access | Times Cited: 3
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 8
Targeted Therapies for Previously “Undruggable” KRAS-Mutated Non–Small Cell Lung Cancer: A Review of Sotorasib and Adagrasib
Natalie Mausey, Zachery Halford
Annals of Pharmacotherapy (2023) Vol. 58, Iss. 6, pp. 622-635
Closed Access | Times Cited: 8
Resistance to KRAS inhibition in advanced non-small cell lung cancer
Katherina Bernadette Sreter, Maria Joana Catarata, Maximilian von Laffert, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Network-based analysis identifies potential therapeutic ingredients of Chinese medicines and their mechanisms toward lung cancer
Mingrui Li, Gui-Yang Zhang, Qiang Tang, et al.
Computers in Biology and Medicine (2024) Vol. 173, pp. 108292-108292
Closed Access | Times Cited: 1
RAS G12C Inhibitors: Three Birds with One Stone
Tessa Seale, Sandra Misale
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 698-700
Closed Access | Times Cited: 1
Current status of molecular diagnostics for lung cancer
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, С. В. Орлов
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 742-765
Open Access | Times Cited: 1
Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy
Rita Nogueiras‐Álvarez, Inês Francisco
British Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 1
Molecular and Clinicopathological Correlates of Wild-Type KRAS Expression in Prostate Cancer
Henry O Ebili, Sebastian A. Omenai, Uchenna Simon Ezenkwa, et al.
annals of urologic oncology (2024)
Open Access | Times Cited: 1
Reprint of: Smoking and pulmonary health in women: A narrative review and behavioral health perspective
Katherine E. Menson, Sulamunn R.M. Coleman
Preventive Medicine (2024) Vol. 188, pp. 108113-108113
Closed Access | Times Cited: 1
Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy
Guomin Gu, Chunling Liu, Xiaodan Zhu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 9
Open Access | Times Cited: 1
FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling
Marion Morel, Weiwen Long
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 762-777
Open Access | Times Cited: 3
Keeping a Track on Leptomeningeal Disease in Non-Small Cell Lung Cancer: A Single Institution Experience with CNSideTM
Sonam Puri, Rachna Malani, A. Chalmers, et al.
Neuro-Oncology Advances (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 3
DNA variants detected in primary and metastatic lung adenocarcinoma: a case report and review of the literature
Christina Kelly, Caitlin Raymond, Song Han, et al.
Laboratory Medicine (2024) Vol. 55, Iss. 5, pp. 658-662
Closed Access
Page 1 - Next Page

Scroll to top